TCMP
SNY icon

Thrive Capital Management (Pennsylvania)’s Sanofi SNY Stock Holding History

Thrive Capital Management (Pennsylvania)’s Portfolio SNY Stock Details SNY Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q1 		– Sell
-5,176
Closed -$257K – 191
2023
Q4 		$257K Sell
5,176
-2,192
-30% -$107K 0.14% 115
2023
Q3 		$395K Sell
7,368
-16
-0.2% -$853 0.22% 76
2023
Q2 		$398K Buy
7,384
+1,942
+36% +$104K 0.23% 75
2023
Q1 		$294K Buy
+5,442
New +$265K 0.19% 93
2022
Q1 		– Sell
-9,464
Closed -$474K – 116
2021
Q4 		$474K Sell
9,464
-8,464
-47% -$419K 0.31% 67
2021
Q3 		$864K Buy
17,928
+2,157
+14% +$110K 0.64% 47
2021
Q2 		$831K Buy
15,771
+5,449
+53% +$284K 0.65% 48
2021
Q1 		$511K Buy
10,322
+2,874
+39% +$138K 0.48% 56
2020
Q4 		$362K Buy
+7,448
New +$367K 0.39% 59

Other funds holding SNY

Dodge & Cox
Dodge & Cox San Francisco, California $191B AUM 17.5% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Fisher Asset Management
Fisher Asset Management Camas, Washington $336B AUM 34.66% 1-Year Est. Return
Boston Partners
Boston Partners Boston, Massachusetts $113B AUM 38.87% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return
MIP
Mondrian Investment Partners London, United Kingdom $6.48B AUM 18.36% 1-Year Est. Return

Thrive Capital Management (Pennsylvania)'s SNY Position: Q1 2024 in Review

Thrive Capital Management (Pennsylvania) sold out of Sanofi (SNY) in Q1 2024, closing a stake of 5,176 shares — an estimated $257K sold.

Thrive Capital Management (Pennsylvania) first reported a position in SNY in Q4 2020 and held it in 9 quarters. The position peaked at $864K in Q3 2021. 713 funds tracked by Wall St. Rank hold SNY as of Q1 2024.

  • Thrive Capital Management (Pennsylvania) reported no remaining Sanofi position as of Q1 2024 after selling out during the quarter.
  • Thrive Capital Management (Pennsylvania) sold 5,176 Sanofi shares in Q1 2024, an estimated $257K.
  • Thrive Capital Management (Pennsylvania) first reported a position in Sanofi in Q4 2020 and held it in 9 quarters.
  • Thrive Capital Management (Pennsylvania)'s Sanofi position peaked at $864K in Q3 2021.
  • 713 funds tracked by Wall St. Rank held Sanofi as of Q1 2024.

Based on Thrive Capital Management (Pennsylvania)'s 13F filing for Q1 2024, filed 13 May 2024.